Partial List of 2020 Attendees

(as of March 2, 2020)
  • Project Leader, Ablynx a Sanofi Co
  • VP Platform Sciences, Adaptimmune Therapeutics plc
  • Market Dev Mgr, Adaptive Biotechnologies
  • Assoc Dir Antibody Discovery, Adimab LLC
  • Scientist, Affibody AB
  • Sr Scientist, Affibody AB
  • Scientific Dir & CSO, Affilogic
  • Research Scientist, Agilent Technologies Ireland Ltd
  • Coordination Dir, Ajinomoto Omnichem NV
  • Sr Scientist, Alligator Bioscience AB
  • Sr Scientist, Alligator Bioscience AB
  • Sr Scientist, Alligator Bioscience AB
  • CTO, Altimmune UK Ltd
  • Dir Research & Early Dev Lead Oncology, Amgen Research Munich GmbH
  • Project Head, Apeiron Biologics AG
  • Professor & Chair, Arabian Gulf University
  • Assoc Dir & Head, AstraZeneca
  • Head, Avvinity Therapeutics
  • Dir Bus Dev, Batavia Biosciences BV
  • Bus Development Mgr, BBI Solutions
  • BioPharma Market Dev Mgr, Bio Rad Labs
  • Clinical Research Scientist, BIOCAD
  • Group Leader, BIOCAD
  • Jr Researcher, BIOCAD
  • Scientist, BIOCAD
  • Scientist, BIOCAD
  • CEO, Biocytogen Boston Corp
  • Research Scientist, BioInvent Intl AB
  • Scientist II, Blueprint Medicines
  • Sr Scientist, Blueprint Medicines
  • Sr Principal Scientist, Boehringer Ingelheim Pharma GmbH & Co KG
  • Assoc Professor of Neurosurgery & Dir, Brigham & Womens Hospital
  • Dir European Bus Dev, Canopy Biosciences
  • Global Sr Dir of Sales, Canopy Biosciences
  • Assoc Dir, Caprion Biosciences Inc
  • Sr Dir, Caprion Biosciences Inc
  • Professor, Cardiff Universtiy
  • Co Founder & VP Discovery Research, Carisma Therapeutics Inc
  • Programme Mgr, Cell & Gene Therapy Catapult
  • VP R&D, Celyad
  • Global Head, Celyad Inc
  • Professor, Central Connecticut State University
  • Bus Devloper, Cerba Research
  • Professor, Charite University Berlin
  • Dir, Chinese PLA General Hospital
  • Sr Scientist, ChromoTek GmbH
  • Sr Editor, Clarivate Analytics
  • scientist, Compugen Ltd
  • Research & Lab Dir, Cordeliers Research Ctr
  • Principal Scientist, Crescendo Biologics Ltd
  • Sr Scientist, Crescendo Biologics Ltd
  • Bus Dev Mgr, Crown Bioscience Inc
  • Scientific Account Manager, Crown Bioscience Inc
  • Sr Scientist, Ctr Leon Berard
  • European Sales & Marketing Mgr, Curiox Biosystems Inc
  • Professor, Dana Farber Cancer Institute
  • Medical Oncologist, Duke University
  • Sr Consultant Regulatory Affairs, ERA Consulting UK Ltd
  • Graduate Student, Erasmus MC
  • Postdoc Research Fellow, Erasmus MC
  • Assoc Professor & Head, Erasmus University
  • Full Professor, ETH Zurich
  • Dir Client Relations, evitria AG
  • Principal Scientist & Project Leader, F Hoffmann La Roche AG
  • VP Preclinical Translational Pharmacology, F star Biotechnology Ltd
  • Head, Formycon AG
  • Scientific Dir, Fred Hutchinson Cancer Research Ctr
  • Study Director, GemPharmatech Co Ltd
  • VP Transgenic Technologies, genOway
  • Head, GlaxoSmithKline
  • Scientific Leader, GlaxoSmithKline
  • CMO, Gossamer Bio
  • Professor & Dir Oncology, Hadassah Medical Organization
  • Sr Dir Bus Dev, HistoGeneX NV
  • Grp Leader, Hubrecht Organoid Technology Foundation
  • Scientist, Hubrecht Organoid Technology Foundation
  • Lab Head Advanced Cell Models Lab, iBET Instituto de Biologia Experimental Tecnologica
  • CEO & Dir, Immetacyte
  • CSO & COO, Immudex
  • Market Dev Mgr, Immudex
  • Bus Dev, Immuneed AB
  • COO, Immuneed AB
  • Sr Scientist & Head, Immuneed AB
  • Bus Dev Mgr, ImmunXperts SA
  • Sr Research Analyst Technology Eval & Med Policy, Independence Blue Cross
  • Principal Investigator, Innate Pharma
  • Head & Professor, Institut Curie
  • Professor, Institute of Cancer Research
  • Team Leader, Institute of Cancer Research
  • Team Leader, Institute of Cancer Research
  • Head, Institute of Hematopathology Hamburg
  • Global VP Sales & Marketing, IRBM Science Pk SpA
  • Dir European Sales, IsoPlexis
  • Field Application Scientist, IsoPlexis
  • Sales Consultant, IsoPlexis
  • Sr Sales Mgr, IsoPlexis
  • Sr Research Scientist, JW CreaGene
  • Sr Research Scientist & Mgr, JW CreaGene
  • Consultant & Sr Lecturer, Kings College London
  • Lecturer, Kings College London
  • PhD Student, Kings College London
  • Professor, Kings College London
  • Professor & Chair Cancer Research, Kings College London
  • Sr Clinical Lecturer & Clinician Scientist, Kings College London
  • Principal Scientist, LifeArc
  • Therapeutic Program Lead, Light Chain Bioscience A brand of Novimmune SA
  • Dir, Ludwig Institute for Cancer Research
  • Assoc Professor, Massachusetts General Hospital
  • Assoc Professor & Dir, Massachusetts General Hospital
  • Asst Professor Medicine, Massachusetts General Hospital
  • Graduate Student, Max Delbrueck Ctr For Molecular Medicine
  • Dir Global Marketing, MaxCyte Inc
  • European Sales Mgr, MaxCyte Inc
  • Exec VP Global Sales, MaxCyte Inc
  • Field Application Scientist, MaxCyte Inc
  • Sales Mgr, MaxCyte Inc
  • Surgical Oncologist & Assoc Professor, Mayo Clinic & Foundation
  • President, MEDICLINK Regenerative Cellular Therapy Ctr
  • VP Translational Medicine & Head, Medigene AG
  • Editor, MedNous
  • Asst VP, MegaPro Biomedical Co Ltd
  • PostDoc Scientist, Melanoma Institute Australia
  • Medical Oncologist & Dir, Memorial Sloan Kettering Cancer Ctr
  • Exec Medical Dir & Head of Companion Diagnostics, Merck & Co Inc
  • Lab Head, Merck Healthcare KGaA
  • Scientific Liaison, Merck KGaA
  • Account Mgr, Merck Millipore
  • Sr VP Global Clinical Dev, Merck Research Labs
  • Sr Scientist, Merus NV
  • Clinical Assessor, MHRA
  • Medical Assessor, MHRA
  • Pre-clinical Assessor, MHRA
  • Quality Assessor, MHRA
  • Head of Cell Engineering R&D, MilliporeSigma
  • Sr Product Mgr, MilliporeSigma
  • Founder & CEO, MindPeak GmbH
  • Assoc Dir R&D, MorphoSys AG
  • Principal Tech Asst, MorphoSys AG
  • CEO, multimmune GmbH
  • PostDoc Fellow, Netherlands Cancer Institute
  • Dir Lab Animal Sciences Program, NIH NCI
  • COO & CMO & Vice Chair, NKMax America Inc
  • Bus Dev Mgr, Oncodesign SA
  • Dir Technology, Oncodesign SA
  • Sr Research Scientist, Orionis Biosciences NV
  • Sr Scientist, Ottawa Health Research Institute
  • Scientist, Oxford Genetics Ltd
  • Sr Scientist, Oxford Genetics Ltd
  • Application Dev Scientist, Oxford Nanoimaging Ltd ONI
  • Business Developer, Oxford Nanoimaging Ltd ONI
  • CEO, Panolos Bioscience
  • CSO, Panolos Bioscience
  • Research Scientist, Panolos Bioscience
  • Clinical Assessor, Paul Ehrlich Institut
  • Lab Head, Peter MacCallum Cancer Ctr
  • Dir In Vivo Pharmacology & Oncology, Pfizer Inc
  • Sr Dir Strategic Dev Europe, Precision for Medicine
  • Global Head, Precision for Medicine Oncology & Rare Disease
  • Sr Dir Strategic Dev, Precision for Medicine Oncology & Rare Disease
  • Principal Scientist, Prokarium
  • Grp Leader Cellular Test Systems & Head, ProQinase GmbH
  • Mgr Bus Dev, ProQinase GmbH
  • Professor, Queen Mary University of London
  • Professor, Cancer Cell Biology, Queen Mary University of London
  • Asst Professor, Queens University
  • CSO, Refuge Biotechnologies Inc
  • Exec Dir ImmunoOncology Dev, Regeneron Pharmaceuticals Inc
  • Research Fellow, Regeneron Pharmaceuticals Inc
  • Sr Dir Bispecifics, Regeneron Pharmaceuticals Inc
  • Sr Dir Immunology & Inflammation, Regeneron Pharmaceuticals Inc
  • Chief Dev Officer, RhoVac ApS
  • Principal Scientist & Grp Leader, Roche Diagnostics GmbH
  • Grp Leader Preclinical Imaging & Histology Core, Roche Innovation Ctr Zurich
  • Sr Scientist, Roche Innovation Ctr Zurich
  • Dir External Innovation & Oncology Discovery, Roche Pharma
  • Dir, Royal Free London Hospital NHS Foundation Trust
  • Scientist, sanofi R&D
  • CSO, Scancell Ltd
  • VP R&D, Shattuck Labs Inc
  • CBO, Sino Biological US Inc
  • Scientist, SOTIO a s
  • Sr Scientist, SOTIO a s
  • Consultant, South West Wales Cancer Institute
  • Professor, Southampton General Hospital
  • Professor & Dir i4PhD Cancer Immunology Pathway, Southampton General Hospital
  • R&D & Innovation Officer, Swansea University
  • Sr VP Immunology & GM, Swedish Orphan Biovitrum AB
  • Project Dir, Symphogen AS
  • Medical Dir, Syneos Health
  • Commercial Lead, Syngene Intl Ltd
  • Sr Mgr, Syngene Intl Ltd
  • Sr Principal Investigator, Syngene Intl Ltd
  • President, Sysmex R&D Ctr Europe GmbH
  • Sr VP, T Cure BioScience Inc
  • Head, Transgene SA
  • Asst Professor, Tufts Medical Ctr
  • Assoc Professor, University College London
  • Professor, University Hospital Tuebingen
  • Graduate Student, University of Cambridge
  • Student, University of Georgia
  • Clinical Scientist & Honorary Medical Oncologist, University of Leeds
  • Student, University of Leeds
  • PostDoc Research Assoc, University of Manchester
  • Postdoc, University of Oxford
  • Chair Gene Immunotherapy, University of Regensburg
  • Sr PostDoc Research Fellow Antibody & Vaccine Grp, University of Southampton
  • Professor & Deputy Head, University Of Stuttgart
  • Research Assoc Professor, University Of Tokyo
  • Assoc Professor, Utrecht University
  • VP Scientific Affairs, Vaccibody AS
  • Professor, Vrije University Brussels
  • Professor, VU Medical Ctr
  • Physician & Researcher, VU University Medical Ctr Amsterdam
  • Dir, Xencor Inc
  • Mgr, Y mAbs Therapeutics Inc
  • Head Clinical Dev, Zellkraftwerk
  • Sr VP Discovery Research, Zymeworks Inc

 


Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag